<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2025.1515537</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>
<italic>Bacillus velezensis</italic> NC-B4 as a promising antifungal agent for biocontrol of <italic>Candida auris</italic>
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yang</surname>
<given-names>Chunxi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1912188/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cui</surname>
<given-names>Chaoyu</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Yanru</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Peng</surname>
<given-names>Zimei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Institute of Clinical Medicine, Jiangxi Provincial People&#x2019;s Hospital, The First Affiliated Hospital of Nanchang Medical College</institution>, <addr-line>Nanchang</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Jiangxi Key Laboratory for Excavation and Utilization of Agricultural Microorganisms, Jiangxi Agricultural University</institution>, <addr-line>Nanchang</addr-line>,&#xa0;<country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Mar&#xed;a Guadalupe Fr&#xed;as De Le&#xf3;n, Hospital Regional de Alta Especialidad de Ixtapaluca, Mexico</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/209403/overview">Ludmila Baltazar</ext-link>, Universidade Federal de Goi&#xe1;s, Brazil</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1780802/overview">Sunna Nabeela</ext-link>, Lundquist Institute for Biomedical Innovation, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Chunxi Yang, <email xlink:href="mailto:chunxiyang@139.com">chunxiyang@139.com</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>02</day>
<month>09</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>15</volume>
<elocation-id>1515537</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>10</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>08</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Yang, Cui, Chen and Peng.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Yang, Cui, Chen and Peng</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>
<italic>Candida auris</italic>, known as the "super fungus", is commonly existed in hospital. The treatment of <italic>C. auris</italic> infection is difficult for its multi-drug resistance and difficult to accurately detect. The use of synthetic antibacterial agents has caused major problems such as drug-resistance and environment pollution and negatively affects non-target species. Microbial biocontrol agents (probiotics) are needed for fungal infection. <italic>Bacillus</italic> and related genera produce a variety of bioactive substances. As probiotics, it has been widely studied in the field of medicine and is a novel microbial factor for biological control.</p>
</sec>
<sec>
<title>Methods</title>
<p>
<italic>B. velezensis</italic> NC-B4 was isolated using gradient dilution method. Then it was identified by phylogenetic analysis and physiological and biochemical characteristics. The antibacterial mechanism of NC-B4 was explored by detecting cellulase, protease and genomic analysis. Then antimicrobial effects were analyzed by detecting the growth and biofilm of <italic>C. auris</italic> BJCA001. Finally, the cytotoxicity and the protective effect on mice were analyzed by cell line and mouse systemic infection models.</p>
</sec>
<sec>
<title>Results</title>
<p>We isolated <italic>B. velezensis</italic> NC-B4, which showed cellulase, protease enzyme activity and antimicrobial effects against human pathogenic fungi by inhibiting the growth of Candida auris, <italic>Cryptococcus neoformans, Candida albicans</italic> and mycelial fungus. <italic>B. velezensis</italic> NC-B4 inhibited the biofilm formation and growth of C. auris. <italic>B. velezensis</italic> NC-B4 has a protective effect against the toxicity of Candida auris in A549 cell line and mouse systemic infection models. The complete genome of <italic>B. velezensis</italic> NC-B4 was 3.93 Mb with a 46.5% G+C content and possessed the macrolactin H, bacillaene, fengycin, difficidin, bacillibactin and bacilysin biosynthesis cluster, which known as key factors in biological control.</p>
</sec>
<sec>
<title>Discussion</title>
<p>The results of the present study indicated that <italic>B. velezensis</italic> NC-B4 has antimicrobial properties for its cellulase, protease and antibacterial secondary metabolites, thereby inhibiting the growth of pathogenic bacteria and the formation of biofilms. <italic>B. velezensis</italic> NC-B4 is expected to be developed as a source for probiotics or new antibiotics.</p>
</sec>
</abstract>
<kwd-group>
<kwd>antifungal activity</kwd>
<kwd>
<italic>Bacillus velezensis</italic> NC-B4</kwd>
<kwd>biological control</kwd>
<kwd>
<italic>Candida auris</italic>
</kwd>
<kwd>genome-sequence analysis</kwd>
</kwd-group>
<counts>
<fig-count count="6"/>
<table-count count="6"/>
<equation-count count="0"/>
<ref-count count="41"/>
<page-count count="14"/>
<word-count count="6673"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Antibiotic Resistance and New Antimicrobial drugs</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>
<italic>Candida auris</italic>, an invasive fungal pathogen commonly colonized in skin, the respiratory tract, and urinary tract, has emerged globally as a multidrug-resistant fungal pathogen (<xref ref-type="bibr" rid="B1">Abdolrasouli et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B37">Welsh et&#xa0;al., 2017</xref>). There are six distinct clades of <italic>C. auris</italic> based on genetic and genomic information and locations of first isolates: Clade I (South Asian), Clade II (East Asian), Clade III (South African), Clade IV (South American), Clade V (Iran), and Clade VI (Singapore) (<xref ref-type="bibr" rid="B3">Bhargava, 2025</xref>). Ninety percent of clinical isolates of <italic>C. auris</italic> are resistant to fluconazole, and their sensitivity to other azole antifungal drugs, 5-fluorocytosine, amphotericin B, and echinocandins is also changeable, which often leads to blood infection with high mortality (<xref ref-type="bibr" rid="B6">Chowdhary et&#xa0;al., 2018</xref>). At present, antifungal drugs are still the main measures to treat <italic>C. auris</italic> infection, but the problems of drug resistance and environmental pollution caused by long-term use of antifungal drugs have attracted more and more attention (<xref ref-type="bibr" rid="B27">Osei Sekyere, 2018</xref>). Therefore, it is urgent to search for new antifungal methods to solve the drug resistance problem.</p>
<p>
<italic>Bacillus</italic> is the most abundant group of bacteria in the rhizosphere of plants (<xref ref-type="bibr" rid="B4">Choudhary and Johri, 2009</xref>; <xref ref-type="bibr" rid="B33">Shao et&#xa0;al., 2022</xref>). The bioactive substances produced by <italic>Bacillus</italic> are harmless to livestock and poultry and can kill bacteria, some fungi, parasites, some viruses, and tumor cells, including drug-resistant strains, and are widely used in industry, agriculture, and medical production (<xref ref-type="bibr" rid="B10">Elshaghabee et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B40">Zalila-Kolsi et&#xa0;al., 2023</xref>). In addition, the microecological preparation prepared by <italic>Bacillus</italic> has played an important role in the treatment of intestinal flora imbalance, <italic>candida</italic> infection, and prevention of wound surface infection (<xref ref-type="bibr" rid="B15">Garvey et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B41">Zou et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B28">Ramesh and Roy, 2023</xref>; <xref ref-type="bibr" rid="B24">Kizhakkekalam, 2022</xref>). As a probiotic, it has been widely studied in the medical field and is an ideal new biological control microbial factor. For example, <italic>Bacillus licheniformis</italic> can inhibit <italic>Staphylococcus</italic>, <italic>Candida albicans</italic>, yeast, and <italic>Escherichia coli</italic>, and was made into capsules and oral liquids with living strains to treat intestinal diseases (<xref ref-type="bibr" rid="B29">Ramirez-Olea et&#xa0;al., 2022</xref>); the combination of intestinal ecological preparation of <italic>Bifidobacterium</italic> and <italic>Bacillus licheniformis</italic> and chemotherapy drugs cannot only kill and promote apoptosis of H22 ascites cancer cells but also prolong the life cycle of tumor mice and improve the effect of chemotherapy, which laid the foundation for clinical trials (<xref ref-type="bibr" rid="B20">Hirozawa et&#xa0;al., 2023</xref>).</p>
<p>There are some reports on the study of <italic>B. velezensis</italic> as a biological control microbial factor, the possible mechanisms of <italic>B. velezensis</italic> exert the antifungal effects are as follows: There are many genes responsible for the biosynthesis of antifungal compounds; it was reported that <italic>B. velezensis</italic> KTA01 can produce lipopeptide, which displayed prominent antifungal activity against <italic>B. dothidea</italic> KACC45481 (<xref ref-type="bibr" rid="B22">Kang et&#xa0;al., 2024</xref>). The research on the mechanism of <italic>B. velezensis</italic> HeN-7 CFS antifungal action demonstrated that HeN-7 CFS induced the membrane lipid peroxidation in <italic>B. sorokiniana</italic>, leading to the disruption of cell membrane integrity and resulting in the leakage of cell contents (<xref ref-type="bibr" rid="B25">Lin et&#xa0;al., 2024</xref>). <italic>B. velezensis</italic> CFS may inhibit <italic>C. fioriniae</italic> through interference with ribosomes, genetic information processing, cell membrane metabolism, and energy metabolism (<xref ref-type="bibr" rid="B13">Fu et&#xa0;al., 2024</xref>).</p>
<p>In this study, we aimed to screen isolates and identify functional characteristics of <italic>B. velezensis</italic> NC-B4 for developing biological control agents against <italic>C. auris</italic>, which is called super fungus. The antifungal effect of <italic>B. velezensis</italic> NC-B4 was detected against yeast and filamentous human pathogenic fungus by measuring the antifungal zone, then the protection of <italic>B. velezensis</italic> NC-B4 on mouse systemic infection with <italic>C. auris</italic> was detected by measuring the fungal burden [colony-forming unit (CFU)] in each organ after <italic>C. auris</italic> infection. We provide an understanding of the antibacterial mechanism of action of <italic>B. velezensis</italic> NC-B4 by detecting extracellular enzyme activity such as cellulase and protease and analyzing the secondary metabolite genes. We also evaluated the toxicity of <italic>B. velezensis</italic> NC-B4 by detecting the killing of NC-B4 on A549 cells. Based on the effective properties of NC-B4 for its antifungal action, we propose NC-B4 be suggested as a useful biological control agent (probiotic) for the medical and health industry.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>Strains and culture conditions</title>
<p>All the strains used in this study are listed in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>. Bacterial strains were grown at 35&#xb0;C with shaking at 200 rpm in Lurai-Bertani broth (10 g tryptone, 5 g yeast extract, and 10 g NaCl in 1 L, pH 7.0). Fungi were grown at 28&#xb0;C in Yeast Extract Peptone Dextrose Medium (10 g yeast extract, 20 g peptone, 20 g dextrose, and 20 g agar in 1 L). <italic>Candida auris</italic> BJCA001, <italic>Cryptococcus neoformans</italic> H99, <italic>Candida albicans</italic> SC5314, and four mycelial fungi were obtained from our laboratory. Bacterial growth was determined by measuring optical density at a wavelength of 600 nm.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Bacterial and fungal strains used in this study.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Strain</th>
<th valign="middle" align="center">Reference or Source</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">
<italic>B. velezensis</italic> NC-B4</td>
<td valign="middle" align="center">This study</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>Candida auris</italic> BJCA001</td>
<td valign="middle" align="center">Laboratory collection</td>
</tr>
<tr>
<td valign="middle" align="center">, <italic>Cryptococcus neoformans</italic> H99</td>
<td valign="middle" align="center">Laboratory collection</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>Candida albicans</italic> SC5314</td>
<td valign="middle" align="center">Laboratory collection</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>Lasiodiplodia theobromae</italic>
</td>
<td valign="middle" align="center">Laboratory collection</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>Absidia</italic>
</td>
<td valign="middle" align="center">Laboratory collection</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>Cunninghamella bertholletiae</italic>
</td>
<td valign="middle" align="center">Laboratory collection</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>Trichophyton schoenleini</italic>
</td>
<td valign="middle" align="center">Laboratory collection</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2_2">
<title>Isolation, screening, and identification of bacterial strains</title>
<p>
<italic>B. velezensis</italic> NC-B4 was collected from plant rhizosphere soil (Nanchang, China) and isolated using the gradient dilution method. In detail, plant rhizosphere soil was collected from a hospital, park, and mountain and prepared into a 10% soil suspension (10<sup>&#x2212;1</sup>), then the soil suspension was diluted by a 10-fold gradient (10<sup>&#x2212;2</sup>, 10<sup>&#x2212;3</sup>, 10<sup>&#x2212;4</sup>, 10<sup>&#x2212;5</sup>). Soil suspension (100 &#xb5;l) of each concentration was spread on the LB plates, and the plates were incubated at 35&#xb0;C until single colonies grew. Then pick up and inoculate the colonies on the YPD plates that contain <italic>C. auris</italic> BJCA001 (10<sup>8</sup> CFU/ml). Finally, we selected the single colony that produced the inhibition zone for further identification. The detection method of physiological and biochemical characteristics refers to Burgey&#x2019;s Manual of Determinative Bacteriology or the instruction of the kit (Hopebio, HBIG14). Molecular identification was performed by using primers (27F/1492R: AGAGTTTGATCCTGGCTCAG/AGAGTTTGATCCTGGCTCAG; gyrA-F/gyrA-R: CAGTCAGGAAATGCGTACGTCCTT/CAAGGTAATGCTCCAGGCATTGCT; rpoB-F/rpoB-R: AGGTCAACTAGTTCAGTATGGAC/AAGAACCGTAACCGGCAACTT) to amplify and sequence the fragments of 16S rRNA, <italic>gyrA</italic>, and <italic>rpoB</italic>, respectively (Lu et&#xa0;al., 2021).</p>
</sec>
<sec id="s2_3">
<title>Phylogenetic and statistical analysis</title>
<p>For phylogenetic analysis, 16S rDNA, <italic>gyrB</italic>, and <italic>rpoB</italic> sequences closely related to our sequences were retrieved from GenBank based on BLAST results from the National Center for Biotechnology Information. Maximum likelihood (ML) phylogenies were constructed using the ML method in IQTREE v1.6.12 (<ext-link ext-link-type="uri" xlink:href="http://iqtree.cibiv.univie.ac.at/">http://iqtree.cibiv.univie.ac.at/</ext-link>). A bootstrap based on 1,000 replicates was analyzed, the confidence of the nodes was evaluated, and all parameters were kept at the default setting (<xref ref-type="bibr" rid="B26">Nguyen et&#xa0;al., 2015</xref>). The trees were visualized using FigureTree v1.4.3 and Adobe Illustrator CC 2018.</p>
</sec>
<sec id="s2_4">
<title>Enzymatic activity analysis</title>
<p>Cellulase activity was evaluated by cellulase detection plate and DNS (di-nitrosalicylic acid) colorimetry methods. Cellulase detection plate method references (<xref ref-type="bibr" rid="B34">Shen et&#xa0;al., 2020</xref>) with minor changes: overnight culture was diluted to an OD600 of 0.01, and 2 &#xb5;l bacterial suspensions were plotted in cellulase detection medium, then the plates were incubated at 35&#xb0;C. After 48h, the plates were stained with 0.5% Congo red for 30 min and incubated with 1 M NaCl solution for 10 min at room temperature. Finally, the plates were washed three times by water, and cellulase activity in the plates was assessed by measuring the diameter of the degradation circle. Each treatment was replicated at least three times. The detailed steps of DNS colorimetry are as follows: <italic>B. velezensis</italic> NC-B4 isolate was grown in LB broth medium for 24h at 37 &#xb1; 2&#xb0;C and then centrifuged at 13,000 rpm for 5 min. 0.5 ml of the supernatant (enzyme solution) was mixed with 1.5 ml of CMC-Na solubilized in phosphate buffer (1%) and incubated at 40&#xb0;C for 30 min. 1.5 ml of dinitrosalicylic (DNS) acid reagent was added, and the mixture was boiled for 5 min; then cooled down and chilled to 25 ml, and the absorbancy was measured at 520 nm. One unit of enzyme activity was defined as 1 &#xb5;mol glucose formed per minute.</p>
<p>Protease activity was evaluated by milk plate. In brief, we prepared an LB plate with 5% milk, then added NC-B4 fermentation broth supernatant (OD600 of 2.0, 3.0, 4.0) and incubated at 37&#xb0;C for 24h. Protease activity was assessed by measuring the diameter of the degradation circle. Another method for analyzing the protease activity was determined by following previously published methods (<xref ref-type="bibr" rid="B36">Wang et&#xa0;al., 2021</xref>).</p>
</sec>
<sec id="s2_5">
<title>Antifungal analysis</title>
<p>The antifungal ability of <italic>B. velezensis</italic> NC-B4 was evaluated using the disk diffusion method against several yeasts and filamentous fungi from clinical isolation. For yeast fungi, we prepared the YPD plate with <italic>C. auris</italic> BJCA001, and 10 &#xb5;l of 1 &#xd7; 10<sup>6</sup> CFUs/ml of the culture suspension was distributed into the hole. After culturing at 35&#xb0;C for 24h, the diameter of the inhibition zone was measured. For filamentous fungi, a pathogenic agar block was prepared and placed in three corners of the plate, and 10 &#xb5;l of 1 &#xd7; 10<sup>6</sup> CFUs/ml of the culture suspension was distributed in the center. Then culturing at 28&#xb0;C for 3&#x2013;5 days, the antifungal activity of NC-B4 was assessed by determining the radial mycelial growth of the fungal pathogen.</p>
</sec>
<sec id="s2_6">
<title>Cell growth analysis</title>
<p>For this assay, we firstly prepared NC-B4 fermentation broth supernatant (OD600 of 3.0), which was filtered by a 0.22 &#xb5;m membrane. <italic>C. auris</italic> BJCA001 cells were incubated overnight (OD600 of 2.0) and then diluted 1,000 times using YPD medium. Then, 50 &#xb5;l of diluted cell suspension containing NC-B4 fermentation broth supernatant (5, 10, 20 &#xb5;l) were added to the 96-well plate in triplicate at 35&#xb0;C for 2 days, then supplemented with YPD medium to 100 &#xb5;l. We measured OD<sub>600</sub> every six hours then plotted the growth curve.</p>
</sec>
<sec id="s2_7">
<title>Biofilm formation assays</title>
<p>Biofilm formation was tested by determining the ability of fungal cells to adhere to the wells of 96-well polypropylene microtiter dishes. <italic>C. auris</italic> was grown overnight at 35&#xb0;C and diluted to 1,000 times by using minimal medium (2 g glycerin, 2g mannitol, 10.5 g K<sub>2</sub>HPO<sub>4</sub>, 4.5 g KH<sub>2</sub>PO<sub>4</sub>, 2 g (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, 0.2 g MgSO<sub>4</sub>&#xb7;7H2O, 0.005 g FeSO<sub>4</sub>, 0.01 g CaCl<sub>2</sub>, 0.002 g MnCl<sub>2</sub> in 1 L). Then <italic>C. auris</italic> suspension [with 0, 5, and 10 &#xb5;l NC-B4 fermentation broth supernatant (OD600 of 3.0)] was added to 96-well polypropylene microtiter plates (100 &#x3bc;l per well) and incubated at 35&#xb0;C with shaking at 200 rpm for 18h. To remove planktonic cells, we discarded the supernatant and washed twice and stained for 20 min with 1% (wt/vol) crystal violet. Then washed using water, added 200 &#x3bc;l ethanol to the well, and measured the absorbance at 595 nm (<xref ref-type="bibr" rid="B21">Huber et&#xa0;al., 2001</xref>).</p>
</sec>
<sec id="s2_8">
<title>Cytotoxicity assays</title>
<p>Cytotoxicity was assessed by measuring the release of lactate dehydrogenase (LDH) from A549 cells. The 1 &#xd7; 10<sup>4</sup> A549 cells were routinely grown in Dulbecco&#x2019;s Modified Eagle Medium (DMEM) supplemented with 1% fetal bovine serum (FBS) in a 96-well plate before infection. <italic>C. auris</italic> BJCA001 strain was grown in YPD medium at 35&#xb0;C, then centrifuged and resuspended in DMEM medium (diluted to OD600 = 1), and different concentrations of NC-B4 fermentation broth supernatant (10%, 20%, and 40%) were added. A549 cells were infected with fungi or fungi with NC-B4 fermentation broth supernatant at 10<sup>9</sup> CFU/ml for 8h. After the 8h incubation, culture supernatants were collected, and LDH in the supernatant was measured following the instruction of the LDH Cytotoxicity Assay Kit (Beyotime Biotechnology, China, C0016). Finally, the cytotoxicity was calculated relative to that of the uninfected control (<xref ref-type="bibr" rid="B39">Yang et&#xa0;al., 2017</xref>).</p>
</sec>
<sec id="s2_9">
<title>Mouse systemic infection models analysis</title>
<p>All the animal experiments were approved by the Ethics Committee at the Jiangxi Provincial People&#x2019;s Hospital (approval number KT2023-012). Male BALB/c mice (20&#x2013;22 g) were used for fungal burden assays; five mice were used for each treated group [phosphate buffered saline (PBS) control, <italic>C. auris</italic> BJCA001, <italic>C. auris</italic> BJCA001 + 50% NC-B4 fermentation broth], and 2.5 &#xd7; 10<sup>7</sup> cells of BJCA001 in 250 &#xb5;l PBS were injected into a mouse via tail vein. Mice were humanely killed at 48h after injection. Different organ tissues (liver, kidney, spleen, lung, and brain) of each infected mouse were removed, weighed, homogenized, and diluted in PBS for CFU calculation on YPD medium (<xref ref-type="bibr" rid="B8">Du et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B38">Xie et&#xa0;al., 2013</xref>).</p>
</sec>
<sec id="s2_10">
<title>Whole genome sequencing and analysis</title>
<p>
<italic>B. velezensis</italic> NC-B4 cells were incubated overnight and collected. Genomic DNA was extracted using a bacterial genome extraction kit (Beyotime Biotechnology, China, D0091) according to the manufacturer&#x2019;s instructions. Whole-genome sequencing was performed using a combination of Illumina NovaSeq 6000 (Illumina, San Diego, CA, USA) and Nanopore PromethION platforms. For short reads sequencing on the NovaSeq 6000 platform, a small fragment library was prepared using the VAHTS<sup>&#xae;</sup> Universal Plus DNA Library Prep Kit for MGI V2/for Illumina V2 (Vazyme, China) with an average insertion size of 300 bp. For long-read sequencing, the libraries were prepared using the SQK-LSK110 ligation kit and using the standard protocol.</p>
<p>The assembly of the genome was performed with Unicycler software (0.5.0). Then, Prodigal (v2.6.3), Aragorn (v1.2.38), RNAmmer (v1.2), and Infernal (v1.1) were used for predicting the coding genes, tRNA, rRNA, and mRNA genes, respectively. BLAST software was used for function annotations of genes against Cluster of Orthologous Groups of proteins (COG, <ext-link ext-link-type="uri" xlink:href="http://blast.ncbi.nlm.nih.gov/Blast.cgi">http://blast.ncbi.nlm.nih.gov/Blast.cgi</ext-link>), and Kyoto Encyclopedia of Genes and Genomes (KEGG, <ext-link ext-link-type="uri" xlink:href="https://www.kegg.jp/">https://www.kegg.jp/</ext-link>) databases.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Screening and identification of bacterial strains</title>
<p>To study the function of microbial biocontrol agents (probiotics) in fungal infection, we collected soil and prepared the soil suspension, then coated the plates. We selected the single clone and inoculated it on a plate that contained <italic>C. auris</italic> BJCA001. Then, screened strains that can inhibit the growth of <italic>C. auris</italic> were marked with a red arrow (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>). Then, we selected the number 4 strain with good antifungal effect; it could form round, milky white, opaque colonies, with dry and wrinkled surfaces, irregular edges, and sunken center on LB agar (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). The cells were rod-shaped, single or paired, the spore is nearly round and proximal, and the sporocysts are enlarged (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>). It was identified as <italic>B. velezensis</italic> based on physiological and biochemical characteristics (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>) and molecular characteristics, including 16S rRNA, <italic>gyrA</italic>, and <italic>rpoB</italic> gene sequences, so we named it Nan chang <italic>B. velezensis</italic> 4(NC-B4). In order to further confirm its classification status, an ML phylogenetic tree was established based on the concatenation of multiple sequences (16S rRNA, <italic>gyrA</italic>, and <italic>rpoB</italic>). In the phylogenetic tree, the NC-B4 and isolates of <italic>B. velezensis</italic> clustered together with 100% bootstrap support (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>). Therefore, the NC-B4 was identified as <italic>B. velezensis</italic>.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Colony morphology and phylogenetic tree. <bold>(A)</bold> Preliminary screening picture, strains which can inhibit the growth of <italic>C. auris</italic> were marked with a red arrow. <bold>(B)</bold> <italic>B. velezensis</italic> NC-B4 was inoculated on LB plate at 35&#xb0;C for 24h, it could form round, milky white, opaque, with dry and wrinkled surface, irregular edge, and sunken center colonies. <bold>(C)</bold> Observation under microscope, the cells were rod-shaped, single or paired, the spore is nearly round, proximal, and the sporocystis are enlarged. <bold>(D)</bold> The phylogenetic tree, a maximum likelihood phylogenetic tree was established based on the concatenation of multiple sequences (16S rRNA, gyrA, and rpoB). In the phylogenetic tree, the NC-B4 and isolates of B velezensis clustered together with 100% bootstrap support.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1515537-g001.tif">
<alt-text content-type="machine-generated">Panel A shows a petri dish with bacterial colonies, some highlighted with red squares. Panel B displays another petri dish with numerous white bacterial colonies. Panel C is a microscopic view of rod-shaped bacteria. Panel D presents a phylogenetic tree comparing Bacillus species, with branch points showing percentage support values.</alt-text>
</graphic>
</fig>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Physiological and biochemical characteristics of <italic>B. velezensis</italic> NC-B4.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Biolog</th>
<th valign="middle" align="center">Result</th>
<th valign="middle" align="center">Biolog</th>
<th valign="middle" align="center">Result</th>
<th valign="middle" align="center">Biolog</th>
<th valign="middle" align="center">Result</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">Cell morphology</td>
<td valign="middle" align="center">rod shape</td>
<td valign="middle" align="center">D-glucose</td>
<td valign="middle" align="center">+</td>
<td valign="middle" align="center">tyrosine hydrolysis test</td>
<td valign="middle" align="center">+</td>
</tr>
<tr>
<td valign="middle" align="center">Gram stain</td>
<td valign="middle" align="center">+</td>
<td valign="middle" align="center">D-fructose</td>
<td valign="middle" align="center">+</td>
<td valign="middle" align="center">H2S production</td>
<td valign="middle" align="center">+</td>
</tr>
<tr>
<td valign="middle" align="center">Amylolysis</td>
<td valign="middle" align="center">&#x2013;</td>
<td valign="middle" align="center">Sucrose</td>
<td valign="middle" align="center">+</td>
<td valign="middle" align="center">Methyl red test</td>
<td valign="middle" align="center">&#x2013;</td>
</tr>
<tr>
<td valign="middle" align="center">catalase test</td>
<td valign="middle" align="center">+</td>
<td valign="middle" align="center">Maltose</td>
<td valign="middle" align="center">+</td>
<td valign="middle" align="center">Indole test</td>
<td valign="middle" align="center">&#x2013;</td>
</tr>
<tr>
<td valign="middle" align="center">PH5.7 Broth</td>
<td valign="middle" align="center">+</td>
<td valign="middle" align="center">Dynamic test</td>
<td valign="middle" align="center">+</td>
<td valign="middle" align="center">urease</td>
<td valign="middle" align="center">&#x2013;</td>
</tr>
<tr>
<td valign="middle" align="center">Nitrate reduction</td>
<td valign="middle" align="center">+</td>
<td valign="middle" align="center">Casein hydrolysis</td>
<td valign="middle" align="center">+</td>
<td valign="middle" align="center">oxidase</td>
<td valign="middle" align="center">&#x2013;</td>
</tr>
<tr>
<td valign="middle" align="center">Gelatin liquefaction</td>
<td valign="middle" align="center">+</td>
<td valign="middle" align="center">Propionate utilization</td>
<td valign="middle" align="center">&#x2013;</td>
<td valign="middle" align="center">Phenylalanine deaminase</td>
<td valign="middle" align="center">&#x2013;</td>
</tr>
<tr>
<td valign="middle" align="center">L-arabinose</td>
<td valign="middle" align="center">+</td>
<td valign="middle" align="center">Citrate utilization</td>
<td valign="middle" align="center">&#x2013;</td>
<td valign="middle" align="center">7% Nacl Salt tolerance test</td>
<td valign="middle" align="center">+</td>
</tr>
<tr>
<td valign="middle" align="center">D-xylose</td>
<td valign="middle" align="center">+</td>
<td valign="middle" align="center">V-P test</td>
<td valign="middle" align="center">&#x2013;</td>
<td valign="middle" align="center">10% Nacl Salt tolerance test</td>
<td valign="middle" align="center">+</td>
</tr>
<tr>
<td valign="middle" align="center">D-mannitol</td>
<td valign="middle" align="center">+</td>
<td valign="middle" align="center">xylan</td>
<td valign="middle" align="center">&#x2013;</td>
<td valign="middle" align="center">Lactose</td>
<td valign="middle" align="center">+</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>+, positive; -, negative.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_2">
<title>Enzyme activity of <italic>B. velezensis</italic> NC-B4</title>
<p>To understand the antifungal mechanism of NC-B4, the extracellular enzyme activity of NC-B4 in different growth stages was detected by the plate method and the absorbance method. As shown in <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>, NC-B4 has an obvious protease activity compared with clear LB medium, and the activity of protease increased with the increase of cell concentration and became stable after OD 600 reached 3.0. Another method (5% milk plates) reached the same conclusion (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>). Similarly, the measured cellulose activity of NC-B4 fermentation broth was 2.7U, 6.8U, and 7.8U at OD 600 2.0, 3.0, and 4.0, respectively, which showed a higher cellulose activity (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). It also showed the same result by the cellulase detection plate method (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Enzyme activity of <italic>B. velezensis</italic> NC-B4. The protease <bold>(A, B)</bold> and cellulase <bold>(C, D)</bold> activities in fermentation broth were detected at different OD values (2.0, 3.0, and 4.0). <bold>(A)</bold> OD442 represents the strength of protease activity, NC-B4 has an obvious protease activity compared with clear LB medium (control) at different OD values. <bold>(B)</bold> NC-B4 fermentation broth can form a decomposition ring on the 5% milk plate, the larger the degradation ring, the stronger the protease activity. The cellulose activity of NC-B4 fermentation broth at OD2.0, 3.0, and 4.0. by absorbance method <bold>(C)</bold> and cellulase detection plate method <bold>(D)</bold>, the higher the enzyme activity value (U) and the larger the degradation circle are, and the stronger of cellulase activity will be. Each experiment was repeated three times.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1515537-g002.tif">
<alt-text content-type="machine-generated">Panel A shows a bar graph comparing protease activity at different OD600 levels for control and NC-B4, with NC-B4 showing higher activity. Panel B displays a petri dish with labeled spots for OD2.0, OD3.0, and OD4.0. Panel C illustrates a bar graph of cellulase activity at various OD levels, with higher activity at OD3.0 and OD4.0. Panel D shows a petri dish with zones labeled OD2.0, OD3.0, and OD4.0 on a red medium.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_3">
<title>
<italic>In-vitro</italic> antifungal effects against human pathogenic fungi</title>
<p>In order to detect whether <italic>B. velezensis</italic> NC-B4 has an antagonistic effect on other human pathogenic fungi, we selected yeast and filamentous fungi for the antagonistic activity assay. As shown in <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>, NC-B4 inhibited the growth of all seven human pathogenic fungi. However, the antagonistic effects on yeast and filamentous fungi were significantly different. NC-B4 strongly inhibited yeast fungi growth of <italic>C. auris</italic> BJCA001, <italic>Cryptococcus neoformans</italic> H99, and <italic>Candida albicans</italic> SC5314, while weakly inhibiting mycelial growth of <italic>Lasiodiplodia theobromae</italic>, <italic>Absidia</italic>, <italic>Cunninghamella bertholletiae</italic>, and <italic>Trichophyton schoenleini</italic>. The detailed antagonistic effect of strain NC-B4 on seven human pathogenic fungi was listed in <xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>; the diameter (mm) of the inhibitory zone or inhibition rate(%)represents antagonistic effects.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Antifungal activity of test strains against human pathogenic fungi. Inhibition effect of <italic>C. auris</italic> BJCA001 <bold>(A)</bold>, <italic>C. neoformans</italic> H99 <bold>(B),</bold> <italic>C. albicans</italic> SC5314 <bold>(C)</bold>, <italic>L. theobromae</italic> <bold>(D)</bold>, <italic>Absidia</italic> <bold>(E)</bold>, <italic>C. bertholletiae</italic> <bold>(F)</bold>, <italic>T. schoenleini</italic> <bold>(G)</bold>. Each experiment was repeated three times. The diameter of inhibitory zone represents antagonistic effects, NC-B4 strongly inhibited yeast fungi growth of <italic>C. auris</italic> BJCA001, Cryptococcus neoformans H99, <italic>Candida albicans</italic> SC5314, while weakly inhibited mycelial growth of <italic>Lasiodiplodia theobromae, Absidia, Cunninghamella bertholletiae</italic>, and <italic>Trichophyton schoenleini</italic>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1515537-g003.tif">
<alt-text content-type="machine-generated">Petri dishes labeled A to G show different fungal growth patterns. Dishes A, B, and C display similar, dense growth. Dish D has a radial spread pattern. Dishes E, F, and G depict more dispersed growth with visible filamentous structures. Each dish has a central point where growth initiated.</alt-text>
</graphic>
</fig>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Antagonistic effect of <italic>B. velezensis</italic> NC-B4 on 7 human pathogenic fungi.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Pathogens</th>
<th valign="middle" align="center">Inhibitory zone diameter (mm)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">
<italic>Candida auris</italic> BJCA001</td>
<td valign="middle" align="center">17.2 &#xb1; 0.91 mm</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>Cryptococcus neoformans</italic> H99</td>
<td valign="middle" align="center">15.2 &#xb1; 0.85 mm</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>Candida albicans</italic> SC5314</td>
<td valign="middle" align="center">8.1 &#xb1; 0.43 mm</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>Cunninghamella bertholletiae</italic>
</td>
<td valign="middle" align="center">4.1 &#xb1; 0.45 mm</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>Trichophyton schoenleini</italic>
</td>
<td valign="middle" align="center">4.1 &#xb1; 0.50 mm</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>Absidia</italic>
</td>
<td valign="middle" align="center">5.9 &#xb1; 0.65 mm</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>Lasiodiplodia theobromae</italic>
</td>
<td valign="middle" align="center">5.0 &#xb1; 0.75 mm</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3_4">
<title>
<italic>B. velezensis</italic> NC-B4 inhibited the biofilm formation and growth of <italic>C. auris</italic>
</title>
<p>Biofilm is an important virulence factor, which is related to antibiotic resistance, escape of microbes from the body&#x2019;s immune system, recalcitrant infections, and biofilm-associated deaths. So we evaluated the capacity of <italic>B. velezensis</italic> NC-B4 to inhibit the biofilm formation of <italic>C. auris</italic>. We obtained supernatant of NC-B4 fermentation broth then tested the effects on the growth curve and biofilm formation of <italic>C. auris</italic> BJCA001. We found NC-B4 fermentation broth can inhibit the growth of <italic>C. auris</italic> when added 5, 10, and 20 &#xb5;l of the supernatant in 100 &#xb5;l, respectively (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). The biofilm production reduced to 67% and 33% when 5 and 10 &#xb5;l of the supernatant were to 100 &#xb5;l, respectively (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>The supernatant <italic>B. velezensis</italic> NC-B4 controls the phenotypes in <italic>C. auris</italic>. Growth curve <bold>(A)</bold>, OD600 represents the density of strain, NC-B4 fermentation broth can inhabit the growth of <italic>C. auris</italic> when added 5, 10, and 20 &#xb5;l of the supernatant in 100 &#xb5;l at different cultivation periods, respectively; effect on <italic>C. auris</italic> biofilm formation <bold>(B)</bold>, OD595 represents the biofilm production, it was reduced when added 5, 10 &#xb5;l of the supernatant in 100 &#xb5;l, respectively. The data shown are the mean of three replicates, and error bars indicate the standard deviation. The experiment was repeated three times.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1515537-g004.tif">
<alt-text content-type="machine-generated">Panel A shows a line graph depicting OD600 measurements over time in hours for four conditions: 0, 5, 10, and 20 are represented by different colored lines. Panel B displays a bar graph of OD595 measurements for NC-B4 supernatant volumes of 0, 5, and 10 microliters, with decreasing values as volume increases. Each bar and line includes error bars.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_5">
<title>The effects of <italic>B. velezensis</italic> NC-B4 fermentation broth on the pathogenicity of <italic>C. auris</italic>
</title>
<p>To detect the effects of fermentation broth on the cytotoxicity of <italic>C. auris</italic>, we measured the cytotoxicity by quantifying the release of LDH into the supernatant of a human cell line, A549. The result showed that the NC-B4 pellet (labeled P in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>) and supernatant (labeled B in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>) did not exhibit toxicity when added at 40 &#xb5;l/100 &#xb5;l; however exogenous addition of the NC-B4 supernatant at 10, 20, and 40 &#xb5;l/100 &#xb5;l (10%, 20%, and 40% B) reduced <italic>C. auris</italic> virulence by 33%, 70%, and 90%, respectively (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). NC-B4 supernatant also reduced <italic>C. auris</italic> infection in the mouse systemic infection models. Measurement of the fungus CFUs in different tissues of the mouse revealed that the addition of 125 &#xb5;l/250 &#xb5;l of NC-B4 supernatant decreased the fungal burden (CFU) in the spleen and brain, while there was no significant difference in the kidney, lung, and liver (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>The effects of <italic>B. velezensis</italic> NC-B4 extraction on the pathogenicity of <italic>C. auris</italic> were determined using the A549 cell line <bold>(A)</bold> and mouse model <bold>(B)</bold>. They were repeated three times. <bold>(A)</bold> Cell cytotoxicity was detected and measured as LDH release. P and B represent adding 40 &#xb5;l of NC-B4 pellet (1 &#xd7; 10<sup>9</sup> CFU/ml) and NC-B4 supernatant. LDH released by <italic>C. auris</italic> BJCA001 was arbitrarily defined as 100% and used to normalize the LDH release ratios of <italic>B. velezensis</italic> NC-B4 fermentation broth and the BJCA001 with different gradient fermentation broth. The data shown are the mean of three replicates, and error bars indicate the standard deviations. <bold>(B)</bold> Measurement of the fungus colony-forming units (CFUs) in different tissues of mouse after 48h of infection, it revealed that the addition of 125 &#xb5;l/250 &#xb5;l of NC-B4 supernatant (50% B) decreased the fungal burden (CFU) in spleen and brain, while there are no significant difference in kidney, lung, and liver.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1515537-g005.tif">
<alt-text content-type="machine-generated">Chart A shows cell cytotoxicity percentages for different treatments with **C. auris**, with the highest in **C. auris** alone. Chart B displays CFUs per gram in various organs, with the highest CFUs observed in the spleen for **C. auris**.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_6">
<title>Genome feature of <italic>B. velezensis</italic> NC-B4</title>
<p>The whole genome of NC-B4 contains a 3,929,792 base pair circular chromosome with a 46.5% G+C content. The genome contains 3,747 protein-coding sequences (CDSs), 27 rRNAs, and 86 tRNAs (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref> and <xref ref-type="table" rid="T4">
<bold>Table&#xa0;4</bold>
</xref>). Among these coding sequences, 3,618 genes were distributed to 23 orthologous clusters (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>). More than 250 genes were classified into functional categories for general function prediction only (<italic>n</italic> = 358), amino acid transport and metabolism (<italic>n</italic> = 349), transcription (<italic>n</italic> = 318), and carbohydrate transport and metabolism (<italic>n</italic> = 293) (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>). To assess the safety of NC-B4, we analyzed the virulence factors in the genome data of the strain NC-B4. Compared with the virulence factors database (VFDB), 71 genes with pident and Qcovs values greater than 50 were obtained and classed. Most of them belong to metabolism-related enzymes; some of them are transporters, regulators, or motility-related proteins; and there are no exotoxin-related genes (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref> and <xref ref-type="table" rid="T5">
<bold>Table&#xa0;5</bold>
</xref>). The gene clusters related to secondary metabolite clusters identified in the genome of <italic>B. velezensis</italic> NC-B4 are listed in <xref ref-type="table" rid="T6">
<bold>Table&#xa0;6</bold>
</xref>. In detail, NC-B4 possesses six metabolite clusters, five of them have 100% similarity, which are conserved in all <italic>B. velezensis</italic> members; the remaining one has 82% similarity. This group of six metabolite clusters comprises macrolactin H, bacillaene, fengycin, difficidin, and bacillibactin gene clusters, encoding the antibacterial or antifungal bioactivity (<xref ref-type="table" rid="T6">
<bold>Table&#xa0;6</bold>
</xref>). The whole genome sequences of the NC-B4 isolate have been deposited in GenBank (Bioproject number: PRJNA995027).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Genome Feature of <italic>B. velezensis</italic> NC-B4. Circular genome maps of <italic>B. velezensis</italic> NC-B4 chromosome <bold>(A)</bold>. Circles from the outside to the center denote rRNA and tRNA gene, reverse strand coding sequence, forward strand coding sequence, GC skew, and GC content. Genome number of virulence factor clusters of orthologous groups category <bold>(B)</bold>. Compared with virulence Factors Database (VFDB), 71 genes with pident and Qcovs values greater than 50 were obtained and classed. Most of them belong to metabolism related enzymes, some of them are transporter, regulator, motility related proteins, there is no exotoxin related genes. Genome number of clusters of orthologous groups category <bold>(C)</bold>. Among these coding sequences, 3,618 genes were distributed to 23 orthologous clusters, more than 250 genes were classified into functional categories for general function prediction only (<italic>n</italic> = 358), amino acid transport and metabolism (<italic>n</italic> = 349), transcription (<italic>n</italic> = 318), carbohydrate transport and metabolism (<italic>n</italic> = 293).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1515537-g006.tif">
<alt-text content-type="machine-generated">(A) Circular genome map of B. velezensis NC-B4, showing genetic features in color-coded rings. (B) Bar chart displaying the number of genes for each virulence factor class, with metabolism-related enzymes having the highest count. (C) Colorful bar chart indicating the number of genes in various function classes, with energy production and conversion having the highest number.</alt-text>
</graphic>
</fig>
<table-wrap id="T4" position="float">
<label>Table&#xa0;4</label>
<caption>
<p>The whole genome overview of <italic>B. velezensis</italic> NC-B4.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" colspan="2" align="center">Chromosome</th>
</tr>
<tr>
<th valign="middle" align="center">Assembly&#xa0;Size (bp)</th>
<th valign="middle" align="center">3929792</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">DNA&#xa0;G+C&#xa0;Content&#xa0;(%GC)</td>
<td valign="middle" align="center">46.5</td>
</tr>
<tr>
<td valign="middle" align="center">CDSs</td>
<td valign="middle" align="center">3747</td>
</tr>
<tr>
<td valign="middle" align="center">rRNAs</td>
<td valign="middle" align="center">27</td>
</tr>
<tr>
<td valign="middle" align="center">tRNAs</td>
<td valign="middle" align="center">86</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T5" position="float">
<label>Table&#xa0;5</label>
<caption>
<p>Virulence factor classes identified in the genome of <italic>B. velezensis</italic> NC-B4.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">SeqID</th>
<th valign="middle" align="center">Pident</th>
<th valign="middle" align="center">Qcovs</th>
<th valign="middle" align="center">Class</th>
<th valign="middle" align="center">Annotation</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">ctg_03427</td>
<td valign="middle" align="center">93.9</td>
<td valign="middle" align="center">100</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">CapC, involved in Poly-gamma-glutamate synthesis</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03428</td>
<td valign="middle" align="center">93.13</td>
<td valign="middle" align="center">100</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">CapB, involved in Poly-gamma-glutamate synthesis</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03737</td>
<td valign="middle" align="center">78.4</td>
<td valign="middle" align="center">100</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">UDP-glucose 4-epimerase GalE</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03009</td>
<td valign="middle" align="center">72.1</td>
<td valign="middle" align="center">100</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">isochorismatase, DhbB</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03237</td>
<td valign="middle" align="center">71.0</td>
<td valign="middle" align="center">100</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">phosphopyruvate hydratase</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_02287</td>
<td valign="middle" align="center">70.4</td>
<td valign="middle" align="center">100</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">NADP-dependent phosphogluconate dehydrogenase</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03012</td>
<td valign="middle" align="center">69.7</td>
<td valign="middle" align="center">100</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">2,3-dihydroxybenzoate-2,3-dehydrogenase, DhbA</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_01050</td>
<td valign="middle" align="center">64.0</td>
<td valign="middle" align="center">100</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">lipoate protein ligase</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03506</td>
<td valign="middle" align="center">62.6</td>
<td valign="middle" align="center">100</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">urease beta subunit UreB, urea amidohydrolase</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_01916</td>
<td valign="middle" align="center">84.4</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">gamma-glutamyltranspeptidase, required for polyglutamate anchoring to peptidoglycan</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03010</td>
<td valign="middle" align="center">81.1</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">2,3-dihydroxybenzoate adenylase DhbE</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03406</td>
<td valign="middle" align="center">78.8</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">UTP--glucose-1-phosphate uridylyltransferase GalU</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03008</td>
<td valign="middle" align="center">70.3</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">non-ribosomal peptide synthetase, DhbF</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03011</td>
<td valign="middle" align="center">65.3</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">isochorismate synthase DhbC</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_01893</td>
<td valign="middle" align="center">64.0</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">UTP--glucose-1-phosphate uridylyltransferase</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_01398</td>
<td valign="middle" align="center">62.1</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">ATP-dependent protease</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03569</td>
<td valign="middle" align="center">59.3</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">nitrate reductase subunit beta</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_01581</td>
<td valign="middle" align="center">58.3</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">signal peptidase II</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_01224</td>
<td valign="middle" align="center">57.2</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">UDP-glucose 4-epimerase GalE</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03509</td>
<td valign="middle" align="center">56.2</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">urease alpha subunit UreA</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03241</td>
<td valign="middle" align="center">55.2</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">type I glyceraldehyde-3-phosphate dehydrogenase</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_02509</td>
<td valign="middle" align="center">54.8</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">mannose-6-phosphate isomerase, class I</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03282</td>
<td valign="middle" align="center">52.7</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">CpsD/CapB family tyrosine-protein kinase</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03415</td>
<td valign="middle" align="center">52.4</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">mannose-6-phosphate isomerase, class I</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_02481</td>
<td valign="middle" align="center">52.0</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">aspartate/glutamate racemase family protein</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03470</td>
<td valign="middle" align="center">51.3</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">CpsD/CapB family tyrosine-protein kinase</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03570</td>
<td valign="middle" align="center">50.6</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">nitrate reductase subunit alpha</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_00876</td>
<td valign="middle" align="center">50.4</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">glutamate-1-semialdehyde 2,1-aminomutase</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_01631</td>
<td valign="middle" align="center">50.0</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">short chain dehydrogenase/reductase family oxidoreductase</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03468</td>
<td valign="middle" align="center">60.0</td>
<td valign="middle" align="center">98</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">UDP-glucose/GDP-mannose dehydrogenase family protein</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03280</td>
<td valign="middle" align="center">57.2</td>
<td valign="middle" align="center">98</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">polysaccharide biosynthesis protein</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_02617</td>
<td valign="middle" align="center">56.5</td>
<td valign="middle" align="center">98</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">glutamate-1-semialdehyde 2,1-aminomutase</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_00912</td>
<td valign="middle" align="center">55.9</td>
<td valign="middle" align="center">98</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">catalase</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03712</td>
<td valign="middle" align="center">55.6</td>
<td valign="middle" align="center">98</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">mannose-6-phosphate isomerase, class I</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03271</td>
<td valign="middle" align="center">63.6</td>
<td valign="middle" align="center">97</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">sugar transferase</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03300</td>
<td valign="middle" align="center">77.9</td>
<td valign="middle" align="center">96</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">ATP-dependent Clp protease proteolytic subunit</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03339</td>
<td valign="middle" align="center">60.0</td>
<td valign="middle" align="center">96</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">prolipoprotein diacylglyceryl transferase</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03269</td>
<td valign="middle" align="center">60.7</td>
<td valign="middle" align="center">95</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">aminotransferase class I/II-fold pyridoxal phosphate-dependent enzyme</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_02406</td>
<td valign="middle" align="center">52.1</td>
<td valign="middle" align="center">95</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">superoxide dismutase</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03508</td>
<td valign="middle" align="center">50.0</td>
<td valign="middle" align="center">94</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">urease alpha subunit UreA</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_01601</td>
<td valign="middle" align="center">50.0</td>
<td valign="middle" align="center">92</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">adenylyl-sulfate kinase</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_01694</td>
<td valign="middle" align="center">61.4</td>
<td valign="middle" align="center">89</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">undecaprenyl diphosphate synthase</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_02121</td>
<td valign="middle" align="center">60.2</td>
<td valign="middle" align="center">89</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">aspartate 1-decarboxylase</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_02047</td>
<td valign="middle" align="center">56.6</td>
<td valign="middle" align="center">89</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">trifunctional thioredoxin/methionine sulfoxide reductase A/B protein</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_02157</td>
<td valign="middle" align="center">58.0</td>
<td valign="middle" align="center">88</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">nucleoside-diphosphate kinase</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03178</td>
<td valign="middle" align="center">50.0</td>
<td valign="middle" align="center">81</td>
<td valign="middle" align="center">Metabolism related enzymes</td>
<td valign="middle" align="center">copper-translocating P-type ATPase</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03426</td>
<td valign="middle" align="center">78.9</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">transporter</td>
<td valign="middle" align="center">CapA, required for Poly-gamma-glutamate transport</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_00409</td>
<td valign="middle" align="center">53.2</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">transporter</td>
<td valign="middle" align="center">iron chelate ABC transporter ATP-binding protein VctC</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03732</td>
<td valign="middle" align="center">51.8</td>
<td valign="middle" align="center">98</td>
<td valign="middle" align="center">transporter</td>
<td valign="middle" align="center">sn-glycerol-3-phosphate ABC transporter ATP-binding protein UgpC</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03066</td>
<td valign="middle" align="center">50.7</td>
<td valign="middle" align="center">98</td>
<td valign="middle" align="center">transporter</td>
<td valign="middle" align="center">sn-glycerol-3-phosphate ABC transporter ATP-binding protein UgpC</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03150</td>
<td valign="middle" align="center">50.2</td>
<td valign="middle" align="center">96</td>
<td valign="middle" align="center">transporter</td>
<td valign="middle" align="center">ABC transporter ATP-binding protein</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03115</td>
<td valign="middle" align="center">65.3</td>
<td valign="middle" align="center">95</td>
<td valign="middle" align="center">transporter</td>
<td valign="middle" align="center">ABC transporter ATP-binding protein</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_01632</td>
<td valign="middle" align="center">63.0</td>
<td valign="middle" align="center">95</td>
<td valign="middle" align="center">transporter</td>
<td valign="middle" align="center">acyl carrier protein</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03469</td>
<td valign="middle" align="center">51.4</td>
<td valign="middle" align="center">100</td>
<td valign="middle" align="center">others</td>
<td valign="middle" align="center">hypothetical protein</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_02056</td>
<td valign="middle" align="center">80.7</td>
<td valign="middle" align="center">100</td>
<td valign="middle" align="center">others</td>
<td valign="middle" align="center">hemolysin III family protein</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_00117</td>
<td valign="middle" align="center">78.4</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">others</td>
<td valign="middle" align="center">endopeptidase Clp ATP-binding chain C</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_01605</td>
<td valign="middle" align="center">52.2</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">others</td>
<td valign="middle" align="center">fibronectin-binding protein</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_00642</td>
<td valign="middle" align="center">74.9</td>
<td valign="middle" align="center">96</td>
<td valign="middle" align="center">others</td>
<td valign="middle" align="center">chaperonin GroEL</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_02451</td>
<td valign="middle" align="center">61.6</td>
<td valign="middle" align="center">93</td>
<td valign="middle" align="center">others</td>
<td valign="middle" align="center">chaperone protein DnaK</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03007</td>
<td valign="middle" align="center">56.3</td>
<td valign="middle" align="center">90</td>
<td valign="middle" align="center">others</td>
<td valign="middle" align="center">MbtH-like protein</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_00145</td>
<td valign="middle" align="center">74.4</td>
<td valign="middle" align="center">99</td>
<td valign="middle" align="center">regulator</td>
<td valign="middle" align="center">elongation factor Tu</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_01674</td>
<td valign="middle" align="center">66.1</td>
<td valign="middle" align="center">98</td>
<td valign="middle" align="center">regulator</td>
<td valign="middle" align="center">response regulator</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_00235</td>
<td valign="middle" align="center">50.2</td>
<td valign="middle" align="center">98</td>
<td valign="middle" align="center">regulator</td>
<td valign="middle" align="center">two-component system response regulator VirR</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_01839</td>
<td valign="middle" align="center">52.6</td>
<td valign="middle" align="center">97</td>
<td valign="middle" align="center">regulator</td>
<td valign="middle" align="center">chemotaxis response regulator CheY</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_02423</td>
<td valign="middle" align="center">62.4</td>
<td valign="middle" align="center">73</td>
<td valign="middle" align="center">regulator</td>
<td valign="middle" align="center">RNA polymerase sigma factor</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03376</td>
<td valign="middle" align="center">50.0</td>
<td valign="middle" align="center">73</td>
<td valign="middle" align="center">regulator</td>
<td valign="middle" align="center">carbon storage regulator CsrA</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_01676</td>
<td valign="middle" align="center">53.6</td>
<td valign="middle" align="center">95</td>
<td valign="middle" align="center">molity related protein</td>
<td valign="middle" align="center">flagellar biosynthesis protein FliP</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_01396</td>
<td valign="middle" align="center">50.0</td>
<td valign="middle" align="center">93</td>
<td valign="middle" align="center">molity related protein</td>
<td valign="middle" align="center">flagellar motor protein MotB</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_01665</td>
<td valign="middle" align="center">55.7</td>
<td valign="middle" align="center">94</td>
<td valign="middle" align="center">molity related protein</td>
<td valign="middle" align="center">flagellar protein export ATPase FliI</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03471</td>
<td valign="middle" align="center">55.0</td>
<td valign="middle" align="center">89</td>
<td valign="middle" align="center">capsular polysaccharide related protein</td>
<td valign="middle" align="center">capsular polysaccharide biosynthesis protein</td>
</tr>
<tr>
<td valign="middle" align="center">ctg_03405</td>
<td valign="middle" align="center">62.1</td>
<td valign="middle" align="center">95</td>
<td valign="middle" align="center">capsular polysaccharide related protein</td>
<td valign="middle" align="center">capsular polysaccharide biosynthesis protein Cps4I</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T6" position="float">
<label>Table&#xa0;6</label>
<caption>
<p>Secondary metabolite clusters identified in the genome of <italic>B. velezensis</italic> NC-B4.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Most similar known cluster</th>
<th valign="middle" align="center">Synthetase Type</th>
<th valign="middle" align="center">Genes</th>
<th valign="middle" align="center">Size (Kb)</th>
<th valign="middle" align="center">Bioactivity</th>
<th valign="middle" align="center">Similarity</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">macrolactin H</td>
<td valign="middle" align="center">transAT-PKS</td>
<td valign="middle" align="center">lacC,defB,pksE_1,fadA_1,pksN_1,acpP_1,acpP_2,acpP_3,rutD_1,yfeW,pdhA,pdhB,pdhD_2,speA_2,suhB</td>
<td valign="middle" align="center">87.8</td>
<td valign="middle" align="center">antibacterial</td>
<td valign="middle" align="center">82%</td>
</tr>
<tr>
<td valign="middle" align="center">bacillaene</td>
<td valign="middle" align="center">NRPS,T3PKS,transAT-PKS</td>
<td valign="middle" align="center">pbpX,tdh_1,miaB,baeB,baeC,baeD,baeE,acpK,pksG_1,pksH,pksI_1,pksJ_1,pksL,pksM,pksN_2,pksR,pksS,aprX</td>
<td valign="middle" align="center">100.6</td>
<td valign="middle" align="center">multiple</td>
<td valign="middle" align="center">100%</td>
</tr>
<tr>
<td valign="middle" align="center">fengycin</td>
<td valign="middle" align="center">NRPS,betalactone,transAT-PKS</td>
<td valign="middle" align="center">yjmD,uxuB,lgrD,dltA_1,dltA_2,fenF,bdhA_1,bioI,bioB_1,bioF,bioK,gtaB_1,crt,yngG,cfiB,fadD3,bcd,ppsE,ppsD,ppsC,ppsB,ppsA,ggt,adh_2</td>
<td valign="middle" align="center">134.3</td>
<td valign="middle" align="center">Antifungal</td>
<td valign="middle" align="center">100%</td>
</tr>
<tr>
<td valign="middle" align="center">difficidin</td>
<td valign="middle" align="center">transAT-PKS</td>
<td valign="middle" align="center">gloB_3,pksI_2,pksG_2,yjiB_2,tdh_2,acpP_4,fadA_2,pksJ_2,fadA_3,fabG_3,menE_1,acpP_5,pksE_2,namA,rutD_3,gndA,pepT_1,pccB,artP</td>
<td valign="middle" align="center">93.8</td>
<td valign="middle" align="center">multiple</td>
<td valign="middle" align="center">100%</td>
</tr>
<tr>
<td valign="middle" align="center">bacillibactin</td>
<td valign="middle" align="center">NRPS,RiPP-like</td>
<td valign="middle" align="center">rutB_2,yueD,mbtH,dhbF,dhbB,dhbE,dhbC,dhbA,besA,yumC,rimJ,ydfG</td>
<td valign="middle" align="center">51.8</td>
<td valign="middle" align="center">antibacterial</td>
<td valign="middle" align="center">100%</td>
</tr>
<tr>
<td valign="middle" align="center">bacilysin</td>
<td valign="middle" align="center">other</td>
<td valign="middle" align="center">yhdG_3,bacG,bacF_2,bacD,bacC_1,rocC_2,rocA,rfbC,rmlD,rfbB,rmlA</td>
<td valign="middle" align="center">41.4</td>
<td valign="middle" align="center">antibacterial</td>
<td valign="middle" align="center">100%</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>
<italic>Bacillus</italic> spp. have been widely studied as microbial biocontrol agents. As a useful microorganism in the medical industry, microecological preparations prepared by <italic>Bacillus</italic> play an important role in the treatment of intestinal flora disorders, <italic>candida</italic> infection, prevention of wound infection, and other medical processes (Garvey et&#xa0;al., 2022; Zou et&#xa0;al., 2022). <italic>B. licheniformis</italic> has an inhibitory effect on <italic>Staphylococcus</italic>, <italic>Candida albicans</italic>, <italic>yeast</italic>, and <italic>Escherichia coli</italic>; capsules and oral liquid made from <italic>B. licheniformis</italic> strains can treat intestinal diseases (<xref ref-type="bibr" rid="B29">Ramirez-Olea et&#xa0;al., 2022</xref>). In addition, intestinal ecological preparation of the combination of <italic>bifidobacterium</italic> and <italic>bacillus licheniformis</italic> combined with chemotherapy drugs cannot only kill and promote apoptosis of H22 ascites cancer cells but also prolong the life cycle of tumor mice and improve the effect of chemotherapy (<xref ref-type="bibr" rid="B17">H. S. et&#xa0;al., 2023</xref>). Here, we isolated and identified a <italic>B. velezensis</italic> NC-B4 (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>) that has antifungal activity (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref> and <xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>).</p>
<p>Cell-wall lytic enzymes exert antifungal effects by destroying the fungal cell wall, cytoplasmic membrane or affect fungal growth and differentiation (<xref ref-type="bibr" rid="B2">Aimanianda et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B5">Choudhary et&#xa0;al., 2014</xref>). For example, cellulase enzymes degrade cell walls by cleaving the &#x3b2;-1,4-D-glycosidic bonds that connect the glucose units containing cellulose (<xref ref-type="bibr" rid="B18">Harrison and Bonning, 2010</xref>), and proteolytic enzymes capable of hydrolyzing polysaccharides adversely affect fungal growth and differentiation by dissolving or disturbing polymers in the cell wall of pathogenic fungi (<xref ref-type="bibr" rid="B19">Hasan et&#xa0;al., 2013</xref>). Here, we detected the potent activity of cellulase and protease in NC-B4 (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>) that supports its correlation with the growth inhibition of various human pathogenic fungi (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>). It has been reported that the enzymes produced by <italic>Bacillus</italic> spp., such as amylase, cellulase, and protease, are highly associated with antifungal activity against <italic>Fusarium oxysporum</italic> pathogens (<xref ref-type="bibr" rid="B9">El-Sersawy et&#xa0;al., 2021</xref>). Moreover, the synergistic effect of cell-wall lytic enzymes and secondary metabolites may enhance the antifungal effect (<xref ref-type="bibr" rid="B23">Kim et&#xa0;al., 2022</xref>).</p>
<p>
<italic>C. auris</italic> is an emerging fungal pathogen that is becoming a serious global health threat. Due to its multidrug-resistant features, invasive infections of <italic>C. auris</italic> often results in high mortality rates (<xref ref-type="bibr" rid="B7">Du et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B35">Spivak and Hanson, 2018</xref>). Here, we showed that the antagonistic activity of NC-B4 on human pathogenic fungi revealed a broad capacity to inhibit the growth of fungus, especially on <italic>C. auris</italic> (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref> and <xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>). Biofilm is an important virulence factor that is related to fungal drug resistance (<xref ref-type="bibr" rid="B30">Rather et&#xa0;al., 2021</xref>). Culture broth of NC-B4 not only inhibited the growth and biofilm formation of <italic>C. auris</italic> (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>) but also can reduce the cytotoxicity of <italic>C. auris</italic> to A549 cells (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). In the mouse systemic infection model, treatment with culture broth of NC-B4 significantly decreased the fungal burden (CFU) in the spleen and brain (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>). For a good microbial biocontrol agent (probiotic), in addition to the function of inhibiting pathogens, the safety of the probiotic strain is very important. Here, we verified that NC-B4 has no toxicity to A549 cells (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). We also analyze virulence factors in the genome data of the strain NC-B4; there are no toxin-related genes (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>).</p>    <p>Through whole genome sequencing and analysis, we predicted the genes and gene clusters involved in secondary metabolites produced by NC-B4. <italic>Bacillus</italic> spp. can produce multiple antimicrobials with a variety of chemical structures, including surfactin, fengycin, macrolactin H, bacillaene, difficidin, bacillibactin, bacilysin, and plantazolicin; they have different effects in the medical industry (<xref ref-type="bibr" rid="B31">Salazar et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B32">Sansinenea and Ortiz, 2011</xref>). In NC-B4, it exhibits a high genetic capacity for synthesizing cyclic lipopeptides (i.e., fengycin, bacillibactin) and polyketides (i.e., macrolactin H, bacillaene, and difficidin) (<xref ref-type="table" rid="T6">
<bold>Table&#xa0;6</bold>
</xref>). Among them, the biosynthetic gene clusters of macrolactin H, bacillibactin, and bacilysin that have antibacterial activity were detected in the NC-B4 genome and had size of 87.8 kb, 51.8 kb, and 41.4 kb, respectively (<xref ref-type="table" rid="T4">
<bold>Table&#xa0;4</bold>
</xref>). In addition, the gene cluster bae and pks associated with the biosynthesis of bacillaene were predicted in the NC-B4 genome (100.6 kb), bacillaene is known as a broad-spectrum antibiotic that inhibits bacterial protein. The gene cluster encoding fengycin synthesis was detected with a size of 134.3 kb, which has an antifungal function.</p>    <p>Numerous studies have been conducted to determine the impact of <italic>Bacillus</italic> secondary metabolite on pathogens (<xref ref-type="bibr" rid="B12">Fira et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B20">Hirozawa et&#xa0;al., 2023</xref>). It is noteworthy that on average around 5% of the whole genome of the <italic>Bacillus</italic> spp. is dedicated to the synthesis of secondary metabolites (<xref ref-type="bibr" rid="B31">Salazar et&#xa0;al., 2023</xref>). <italic>B. subtilis</italic> pB2-L produced plipastatin (the fengycin family), which inhibits <italic>F. oxysporum</italic> mycelium growth (<xref ref-type="bibr" rid="B14">Gao et&#xa0;al., 2017</xref>). <italic>B. amyloliquefaciens</italic> S76&#x2013;3 produced plipastatin A and iturin A, which have clear antagonistic effects on <italic>F. graminearum</italic> (<xref ref-type="bibr" rid="B16">Gong et&#xa0;al., 2015</xref>). <italic>B. velezensis</italic> produces secondary metabolites and enzymes such as protease, chitinase, cellulase, and glucanase, and it inhibits <italic>B. cinerea</italic> growth, and so on (<xref ref-type="bibr" rid="B11">Fazle and Baek, 2020</xref>). However, it has only been reported that <italic>Bacillus</italic> can inhibit plant pathogenic fungi, and its inhibitory effect on human pathogenic fungi has not been reported (<xref ref-type="bibr" rid="B12">Fira et&#xa0;al., 2018</xref>). Here, we found <italic>B.velezensis</italic> NC-B4 also produces a variety of secondary metabolites and enzymes such as protease and cellulase, which have significant antagonistic effects on human pathogenic fungi, especially on <italic>C. auris</italic>. The whole genome analysis of secondary metabolites and the detection of enzymes provide scientific evidence of the effectiveness of NC-B4 as a biocontrol agent.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/supplementary material.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>Ethical approval was in accordance with the local legislation and institutional requirements. All the animal experiments were approved by the Ethics Committee at the Jiangxi Provincial People&#x2019;s Hospital (approval number KT2023-012).</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>CY: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. CC: Data curation, Methodology, Supervision, Writing &#x2013; original draft. YC: Data curation, Formal Analysis, Supervision, Writing &#x2013; original draft. ZP: Data curation, Formal Analysis, Methodology, Writing &#x2013; original draft.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research and/or publication of this article. This research was supported by Jiangxi Provincial Natural Science Foundation (Grant No. 20242BAB25336, 20232BAB213051, 20212BAB216059, 20252BAC200540), the Health Commission of Jiangxi Province (Grant No. 202310199) and the Science and Technology Research Project of Jiangxi Provincial Department of Education (Grant No. GJJ2203554).</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdolrasouli</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Armstrong James</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Ryan</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Schelenz</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with <italic>Candida auris</italic>
</article-title>. <source>Mycoses.</source> <volume>60</volume>, <fpage>758</fpage>&#x2013;<lpage>763</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/myc.12699</pub-id>, PMID: <pub-id pub-id-type="pmid">28872735</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aimanianda</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Simenel</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Garnaud</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Clavaud</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Tada</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Barbin</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>The dual activity responsible for the elongation and branching of &#x3b2;-(1,3)-glucan in the fungal cell wall</article-title>. <source>mBio.</source> <volume>8</volume>, <elocation-id>e00619-17</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.00619-17</pub-id>, PMID: <pub-id pub-id-type="pmid">28634239</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhargava</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Klamer</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ortiz</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Saravolatz</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>
<italic>Candida auris</italic>: A continuing threat</article-title>. <source>Microorganisms.</source> <volume>13</volume>, <elocation-id>652</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/microorganisms13030652</pub-id>, PMID: <pub-id pub-id-type="pmid">40142543</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choudhary</surname> <given-names>D. K.</given-names>
</name>
<name>
<surname>Johri</surname> <given-names>B. N.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Interactions of <italic>Bacillus</italic> spp. and plants &#x2013; With special reference to induced systemic resistance (ISR)</article-title>. <source>Microbiol. Res.</source> <volume>164</volume>, <fpage>493</fpage>&#x2013;<lpage>513</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micres.2008.08.007</pub-id>, PMID: <pub-id pub-id-type="pmid">18845426</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choudhary</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Nagpure</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Gupta</surname> <given-names>R. K.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Fungal cell-wall lytic enzymes, antifungal metabolite(s) production, and characterization from <italic>Streptomyces exfoliatus</italic> MT9 for controlling fruit-rotting fungi</article-title>. <source>J. Basic Microbiol.</source> <volume>54</volume>, <fpage>1295</fpage>&#x2013;<lpage>1309</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jobm.201400380</pub-id>, PMID: <pub-id pub-id-type="pmid">25143015</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chowdhary</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Prakash</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Kordalewska</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Sarma</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>A multicentre study of antifungal susceptibility patterns among 350 <italic>Candida auris</italic> isolates (2009-17) in India: role of the <italic>EGR11</italic> and <italic>FKS1</italic> genes in azole and echinocandin resistance</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>73</volume>, <fpage>891</fpage>&#x2013;<lpage>899</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jac/dkx480</pub-id>, PMID: <pub-id pub-id-type="pmid">29325167</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Bing</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Ennis</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Nobile</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>G.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>
<italic>Candida auris</italic>: epidemiology, biology, antifungal resistance, and virulence</article-title>. <source>PloS Pathog.</source> <volume>16</volume>, <elocation-id>e1008921</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1008921</pub-id>, PMID: <pub-id pub-id-type="pmid">33091071</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Guan</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Tong</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Roles of <italic>Candida albicans</italic> GAT2, a GATA-type zinc finger transcription factor, in biofilm formation, filamentous growth and virulence</article-title>. <source>PloS One</source> <volume>7</volume>, <elocation-id>e29707</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0029707</pub-id>, PMID: <pub-id pub-id-type="pmid">22276126</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Sersawy</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Hassan</surname> <given-names>S. E.</given-names>
</name>
<name>
<surname>El-Ghamry</surname> <given-names>A. A.</given-names>
</name>
<name>
<surname>El-Gwad</surname> <given-names>A. M. A.</given-names>
</name>
<name>
<surname>Fouda</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Implication of plant growth-promoting rhizobacteria of <italic>Bacillus</italic> spp. as biocontrol agents against wilt disease caused by <italic>Fusarium oxysporum</italic> Schlecht. in <italic>Vicia faba</italic> L.</article-title> <source>Biomol. Concepts.</source> <volume>12</volume>, <fpage>197</fpage>&#x2013;<lpage>214</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1515/bmc-2021-0020</pub-id>, PMID: <pub-id pub-id-type="pmid">35041304</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elshaghabee</surname> <given-names>F. M. F.</given-names>
</name>
<name>
<surname>Rokana</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Gulhane</surname> <given-names>R. D.</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Panwar</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>
<italic>Bacillus</italic> as potential probiotics: status, concerns, and future perspectives</article-title>. <source>Front. Microbiol.</source> <volume>8</volume>, <elocation-id>1490</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2017.01490</pub-id>, PMID: <pub-id pub-id-type="pmid">28848511</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fazle Rabbee</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Baek</surname> <given-names>K. H.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Antimicrobial activities of lipopeptides and polyketides of <italic>Bacillus velezensis</italic> for agricultural applications</article-title>. <source>Molecules.</source> <volume>25</volume>, <elocation-id>4973</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules25214973</pub-id>, PMID: <pub-id pub-id-type="pmid">33121115</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fira</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Dimki&#x107;</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Beri&#x107;</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Lozo</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Stankovi&#x107;</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Biological control of plant pathogens by <italic>Bacillus</italic> species</article-title>. <source>J. Biotechnol.</source> <volume>285</volume>, <fpage>44</fpage>&#x2013;<lpage>55</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jbiotec.2018.07.044</pub-id>, PMID: <pub-id pub-id-type="pmid">30172784</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Wan</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Identification of the <italic>Ilex macrocarpa</italic> anthracnose pathogen and the antifungal potential of the cell-free supernatant of <italic>Bacillus velezensis</italic> against <italic>Colletotrichum fioriniae</italic>
</article-title>. <source>Front. Microbiol.</source> <volume>15</volume>, <elocation-id>1419436</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2024.1419436</pub-id>, PMID: <pub-id pub-id-type="pmid">38966396</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Han</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Qu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Bie</surname> <given-names>X.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Plipastatin and surfactin coproduction by <italic>Bacillus subtilis</italic> pB2-L and their effects on microorganisms</article-title>. <source>Antonie. Van. Leeuwenhoek.</source> <volume>110</volume>, <fpage>1007</fpage>&#x2013;<lpage>1018</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10482-017-0874-y</pub-id>, PMID: <pub-id pub-id-type="pmid">28477175</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garvey</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Mah</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Blonquist</surname> <given-names>T. M.</given-names>
</name>
<name>
<surname>Kaden</surname> <given-names>V. N.</given-names>
</name>
<name>
<surname>Spears</surname> <given-names>J. L.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The probiotic <italic>Bacillus subtilis</italic> BS50 decreases gastrointestinal symptoms in healthy adults: a randomized, double-blind, placebo-controlled trial</article-title>. <source>Gut Microbes</source> <volume>14</volume>, <elocation-id>2122668</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/19490976.2022.2122668</pub-id>, PMID: <pub-id pub-id-type="pmid">36269141</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gong</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Song</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>W.</given-names>
</name>
<name>
<surname>He</surname> <given-names>W.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Antagonistic mechanism of iturin A and plipastatin A from <italic>Bacillus amyloliquefaciens</italic> s76&#x2013;3 from wheat spikes against <italic>Fusarium graminearum</italic>
</article-title>. <source>PloS One</source> <volume>10</volume>, <elocation-id>e116871</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0116871</pub-id>, PMID: <pub-id pub-id-type="pmid">25689464</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>H</surname> <given-names>S. R.</given-names>
</name>
<name>
<surname>Halami</surname> <given-names>P. M.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>The combined effect of potential probiotic <italic>Bacillus licheniformis</italic> MCC 2514 and <italic>Bifidobacterium breve</italic> NCIM 5671 towards anti-inflammatory activity on HT-29 cell lines</article-title>. <source>Probiotics Antimicrob. Proteins.</source> <volume>15</volume>, <fpage>351</fpage>&#x2013;<lpage>362</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12602-021-09851-y</pub-id>, PMID: <pub-id pub-id-type="pmid">34581975</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harrison</surname> <given-names>R. L.</given-names>
</name>
<name>
<surname>Bonning</surname> <given-names>B. C.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Proteases as insecticidal agents</article-title>. <source>Toxins.</source> <volume>2</volume>, <fpage>935</fpage>&#x2013;<lpage>953</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/toxins2050935</pub-id>, PMID: <pub-id pub-id-type="pmid">22069618</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasan</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Ahmad</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Purwar</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Khan</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Kundan</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Gupta</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Production of extracellular enzymes in the entomopathogenic fungus <italic>Verticillium lecanii</italic>
</article-title>. <source>Bioinformation.</source> <volume>9</volume>, <fpage>238</fpage>&#x2013;<lpage>242</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.6026/97320630009238</pub-id>, PMID: <pub-id pub-id-type="pmid">23515428</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirozawa</surname> <given-names>M. T.</given-names>
</name>
<name>
<surname>Ono</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Suguiura</surname> <given-names>I. M. D. S.</given-names>
</name>
<name>
<surname>Bordini</surname> <given-names>J. G.</given-names>
</name>
<name>
<surname>Ono</surname> <given-names>E. Y. S.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Lactic acid bacteria and <italic>Bacillus</italic> spp. as fungal biological control agents</article-title>. <source>J. Appl. Microbiol.</source> <volume>134</volume>, <elocation-id>lxac083</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jambio/lxac083</pub-id>, PMID: <pub-id pub-id-type="pmid">36724273</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huber</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Riedel</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Hentzer</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Heydorn</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Gotschlich</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Givskov</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2001</year>). <article-title>The <italic>cep</italic> quorum-sensing system of <italic>Burkholderia cepacia</italic> H111 controls biofilm formation and swarming motility</article-title>. <source>Microbiol. (Reading).</source> <volume>147</volume>, <fpage>2517</fpage>&#x2013;<lpage>2528</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/00221287-147-9-2517</pub-id>, PMID: <pub-id pub-id-type="pmid">11535791</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname> <given-names>T. A.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Hahn</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Shin</surname> <given-names>J. H.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>W. C.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Biocontrol of peach gummosis by <italic>Bacillus velezensis</italic> KTA01 and its antifungal mechanism</article-title>. <source>J. Microbiol. Biotechnol.</source> <volume>34</volume>, <fpage>296</fpage>&#x2013;<lpage>305</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4014/jmb.2310.10005</pub-id>, PMID: <pub-id pub-id-type="pmid">38073404</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Song</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>P. I.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>
<italic>Bacillus velezensis</italic> TSA32&#x2013;1 as a promising agent for biocontrol of plant pathogenic fungi</article-title>. <source>J. Fungi.</source> <volume>8</volume>, <elocation-id>1053</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/jof8101053</pub-id>, PMID: <pub-id pub-id-type="pmid">36294618</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kizhakkekalam</surname> <given-names>V. K.</given-names>
</name>
<name>
<surname>Chakraborty</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Krishnan</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Antibacterial and wound healing potential of topical formulation of marine symbiotic <italic>Bacillus</italic>
</article-title>. <source>Arch. Microbiol.</source> <volume>204</volume>, <fpage>648</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00203-022-03246-5</pub-id>, PMID: <pub-id pub-id-type="pmid">36166149</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Hou</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Antifungal potential and mechanism of <italic>Bacillus velezensis</italic> HeN-7 isolated from tobacco leaves on <italic>Bipolaris sorokiniana</italic>
</article-title>. <source>Curr. Microbiol.</source> <volume>81</volume>, <fpage>340</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00284-024-03858-8</pub-id>, PMID: <pub-id pub-id-type="pmid">39225871</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname> <given-names>L. T.</given-names>
</name>
<name>
<surname>Schmidt</surname> <given-names>H. A.</given-names>
</name>
<name>
<surname>von Haeseler</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Minh</surname> <given-names>B. Q.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies</article-title>. <source>Mol. Biol. Evol.</source> <volume>32</volume>, <fpage>268</fpage>&#x2013;<lpage>274</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/molbev/msu300</pub-id>, PMID: <pub-id pub-id-type="pmid">25371430</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osei Sekyere</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>
<italic>Candida auris</italic>: a systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen</article-title>. <source>Microbiologyopen.</source> <volume>7</volume>, <elocation-id>e00901</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/mbo3.901</pub-id>, PMID: <pub-id pub-id-type="pmid">29345117</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramesh</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Roy</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Roy</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>The elucidation of the multimodal action of the investigational anti-<italic>Candida</italic> lipopeptide (AF<sub>4</sub>) lead from <italic>Bacillus subtilis</italic>
</article-title>. <source>Front. Mol. Biosci.</source> <volume>10</volume>, <elocation-id>1248444</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmolb.2023.1248444</pub-id>, PMID: <pub-id pub-id-type="pmid">38131013</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramirez-Olea</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Reyes-Ballesteros</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Chavez-Santoscoy</surname> <given-names>R. A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Potential application of the probiotic <italic>Bacillus licheniformis</italic> as an adjuvant in the treatment of diseases in humans and animals: a systematic review</article-title>. <source>Front. Microbiol.</source> <volume>13</volume>, <elocation-id>993451</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2022.993451</pub-id>, PMID: <pub-id pub-id-type="pmid">36225361</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rather</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Gupta</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Mandal</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Microbial biofilm: formation, architecture, antibiotic resistance, and control strategies</article-title>. <source>Braz. J. Microbiol.</source> <volume>52</volume>, <fpage>1701</fpage>&#x2013;<lpage>1718</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s42770-021-00624-x</pub-id>, PMID: <pub-id pub-id-type="pmid">34558029</pub-id></citation></ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salazar</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Ortiz</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Keswani</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Minkina</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Mandzhieva</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Pratap Singh</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>
<italic>Bacillus</italic> spp. as bio-factories for antifungal secondary metabolites: innovation beyond whole organism formulations</article-title>. <source>Microb. Ecol.</source> <volume>86</volume>, <fpage>1</fpage>&#x2013;<lpage>24</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00248-022-02044-2</pub-id>, PMID: <pub-id pub-id-type="pmid">35604432</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sansinenea</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Ortiz</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Secondary metabolites of soil <italic>Bacillus</italic> spp</article-title>. <source>Biotechnol. Lett.</source> <volume>33</volume>, <fpage>1523</fpage>&#x2013;<lpage>1538</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10529-011-0617-5</pub-id>, PMID: <pub-id pub-id-type="pmid">21528405</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shao</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>J.</given-names>
</name>
<name>
<surname>&#x160;tefani&#x10d;</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Lv</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>B.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Annulment of bacterial antagonism improves plant beneficial activity of a <italic>Bacillus velezensis</italic> consortium</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>88</volume>, <elocation-id>e0024022</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/aem.00240-22</pub-id>, PMID: <pub-id pub-id-type="pmid">35380452</pub-id></citation></ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Song</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>
<italic>Ralstonia solanacearum</italic> promotes pathogenicity by utilizingl -glutamic acid from host plants</article-title>. <source>Mol. Plant Pathol.</source> <volume>21</volume>, <fpage>1099</fpage>&#x2013;<lpage>1110</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/mpp.12963</pub-id>, PMID: <pub-id pub-id-type="pmid">32599676</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spivak</surname> <given-names>E. S.</given-names>
</name>
<name>
<surname>Hanson</surname> <given-names>K. E.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>
<italic>Candida auris</italic>: an emerging fungal pathogen</article-title>. <source>J. Clin. Microbiol.</source> <volume>56</volume>, <elocation-id>e1588-17</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JCM.01588-17</pub-id>, PMID: <pub-id pub-id-type="pmid">29167291</pub-id></citation></ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Song</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>A LysR family transcriptional regulator modulates <italic>Burkholderia cenocepacia</italic> biofilm formation and protease production</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>87</volume>, <elocation-id>e00202-21</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AEM.00202-21</pub-id>, PMID: <pub-id pub-id-type="pmid">33811025</pub-id></citation></ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Welsh</surname> <given-names>R. M.</given-names>
</name>
<name>
<surname>Bentz</surname> <given-names>M. L.</given-names>
</name>
<name>
<surname>Shams</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Houston</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Lyons</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Rose</surname> <given-names>L. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast <italic>Candida auris</italic> on a plastic health care surface</article-title>. <source>J. Clin. Microbiol.</source> <volume>55</volume>, <fpage>2996</fpage>&#x2013;<lpage>3005</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JCM.00921-17</pub-id>, PMID: <pub-id pub-id-type="pmid">28747370</pub-id></citation></ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Tao</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Nobile</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Tong</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Guan</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>White-opaque switching in natural <italic>MTL</italic>a/&#x3b1; isolates of <italic>Candida albicans</italic>: evolutionary implications for roles in host adaptation, pathogenesis, and sex</article-title>. <source>PloS Biol.</source> <volume>11</volume>, <elocation-id>e1001525</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pbio.1001525</pub-id>, PMID: <pub-id pub-id-type="pmid">23555196</pub-id></citation></ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Kan</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Song</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>
<italic>Burkholderia cenocepacia</italic> integrates <italic>cis</italic>-2-dodecenoic acid and cyclic dimeric guanosine monophosphate signals to control virulence</article-title>. <source>Proc. Natl. Acad. Sci. - Pnas.</source> <volume>114</volume>, <fpage>13006</fpage>&#x2013;<lpage>13011</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1709048114</pub-id>, PMID: <pub-id pub-id-type="pmid">29158389</pub-id></citation></ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zalila-Kolsi</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Ben-Mahmoud</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Al-Barazie</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>
<italic>Bacillus amyloliquefaciens</italic>: harnessing its potential for industrial, medical, and agricultural applications&#x2014;a comprehensive review</article-title>. <source>Microorganisms.</source> <volume>11</volume>, <elocation-id>2215</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/microorganisms11092215</pub-id>, PMID: <pub-id pub-id-type="pmid">37764059</pub-id></citation></ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zou</surname> <given-names>X. Y.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Tu</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>M. L.</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>R. D.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>
<italic>Bacillus subtilis</italic> inhibits intestinal inflammation and oxidative stress by regulating gut flora and related metabolites in laying hens</article-title>. <source>Animal</source> <volume>16</volume>, <elocation-id>100474</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.animal.2022.100474</pub-id>, PMID: <pub-id pub-id-type="pmid">35220172</pub-id></citation></ref>
</ref-list>
</back>
</article>